Signal Advisors Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$739K Sell
2,041
-34
-2% -$11.6K 0.04% 344
2026
Q1
$730K Sell
2,075
-208
-9% -$74.2K 0.05% 302
2025
Q4
$747K Sell
2,283
-791
-26% -$251K 0.06% 240
2025
Q3
$867K Sell
3,074
-3,226
-51% -$936K 0.08% 181
2025
Q2
$1.76M Buy
6,300
+4,431
+237% +$1.26M 0.14% 150
2025
Q1
$582K Sell
1,869
-12
-0.6% -$3.54K 0.06% 254
2024
Q4
$490K Buy
1,881
+190
+11% +$56.4K 0.06% 266
2024
Q3
$545K Buy
+1,691
New +$553K 0.08% 238

Other funds holding AMGN

Signal Advisors Wealth's AMGN Position: Q2 2026 in Review

Signal Advisors Wealth reduced its Amgen (AMGN) stake by 1.6% in Q2 2026, selling an estimated $11.6K and leaving 2,041 shares worth $739K. The position accounts for 0.04% of the portfolio, ranked #344.

Signal Advisors Wealth first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.76M in Q2 2025. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Signal Advisors Wealth held 2,041 shares of Amgen worth $739K as of Q2 2026.
  • Signal Advisors Wealth sold 34 Amgen shares in Q2 2026, an estimated $11.6K.
  • Amgen made up 0.04% of Signal Advisors Wealth's portfolio in Q2 2026, its #344 holding.
  • Signal Advisors Wealth first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • Signal Advisors Wealth's Amgen position peaked at $1.76M in Q2 2025.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.